STOCKS CLIMB WITH U.S. JOBS DATA FRONT OF MIND

RBC Capital Markets raises S&P 500 year-end target to 5,700

ALXO Jul 2024 19.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.7000

0.0000

(0.00%)

As of 12:58PM EDT. Market open.

Loading interactive chart...

Zacks
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
Longboard (LBPH) gains 14% as the FDA grants the Breakthrough Therapy designation to its investigational epilepsy treatment candidate, bexicaserin, for patients aged two years or older.
Zacks
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
Apellis (APLS) declines as CHMP issues a second negative opinion for the approval of intravitreal pegcetacoplan to treat GA in the EU. The company plans to seek re-examination of the same.
Zacks
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of Translarna to treat nmDMD in the EU.